carvedilol has been researched along with 8-hydroxy-2'-deoxyguanosine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, SS; Choi, YS; Kim, JU; Lee, J; Lee, M; Song, KI | 1 |
| Banba, K; Kimura, H; Kono, Y; Kusano, KF; Matsubara, H; Miura, A; Nagase, S; Nakamura, K; Nishii, N; Ohe, T; Sakuragi, S; Watanabe, A | 1 |
| Chen, JW; Chen, YH; Chen, YL; Leu, HB; Lin, FY; Lin, SJ; Wu, TC | 1 |
| De Velasco, MA; Hayashi, T; Ishii, T; Nishioka, T; Nose, K; Saitou, Y; Uemura, H | 1 |
| Akashi, S; Doi, M; Kobayashi, S; Kunitsugu, I; Matsuzaki, M; Murakami, W; Nao, T; Okamura, T; Okuda, S; Susa, T; Tanaka, T; Ueyama, T; Wada, Y; Yamada, J; Yano, M | 1 |
2 trial(s) available for carvedilol and 8-hydroxy-2'-deoxyguanosine
| Article | Year |
|---|---|
Carvedilol reduces plasma 8-hydroxy-2'-deoxyguanosine in mild to moderate hypertension: a pilot study.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Antihypertensive Agents; Antioxidants; C-Reactive Protein; Carbazoles; Carvedilol; Deoxyguanosine; DNA Damage; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pilot Projects; Propanolamines; Severity of Illness Index | 2005 |
Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adrenergic beta-Antagonists; Adult; Aged; Biomarkers; Carbazoles; Cardiac Output, Low; Carvedilol; Deoxyguanosine; DNA Damage; Female; Heart; Heart Rate; Humans; Immunohistochemistry; Male; Middle Aged; Myocardium; Oxidative Stress; Propanolamines | 2006 |
3 other study(ies) available for carvedilol and 8-hydroxy-2'-deoxyguanosine
| Article | Year |
|---|---|
Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Aorta, Abdominal; Atherosclerosis; Carbazoles; Carvedilol; Cells, Cultured; Deoxyguanosine; Diet, Atherogenic; Humans; Hyperplasia; Male; Matrix Metalloproteinase Inhibitors; Probucol; Propanolamines; Rabbits; RNA, Messenger; Tumor Necrosis Factor-alpha; Tunica Intima | 2007 |
Carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antihypertensive Agents; Apoptosis; Carbazoles; Carvedilol; Creatinine; Deoxyguanosine; Disease Models, Animal; Epithelial Cells; Kidney Tubules; Male; Oxidative Stress; Propanolamines; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Reperfusion Injury; Superoxide Dismutase | 2010 |
Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adrenergic beta-Antagonists; Adult; Aged; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Death, Sudden, Cardiac; Deoxyguanosine; Female; Follow-Up Studies; Heart Failure, Systolic; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Predictive Value of Tests; Propanolamines; Prospective Studies; Risk Factors; Treatment Outcome | 2012 |